All entries for: Vertex Pharmaceuticals

November 4, 2025

Vertex Pharmaceuticals

Neutral Outlook

Providence, RI
5,001-10,000 employees

We cannot, however, predict how changes in the law, including through the Inflation Reduction Act of 2022 and passage of state laws (e.g., transparency laws and prescription drug affordability boards), will affect our ability to negotiate successfully with third-party payors and distribute our products.

Disease Area: Endocrinology, Hematology, Multiple, Rare Diseases, Respiratory Diseases
Drug Type: Biologic, Small Molecule
June 12, 2025

Vertex Pharmaceuticals

Layoffs

Providence, RI
5,001-10,000 employees

Just months after shelving its cell therapy–device combo for type 1 diabetes, Vertex Pharmaceuticals is parting ways with 140 employees, according to a Worker Adjustment and Retraining Notification letter dated June 6. The layoffs will heavily focus on the company’s Rhode Island operations, where 125 employees will be affected, as per the state’s WARN posting. There, Vertex is consolidating its three Providence sites, which currently form somewhat of an “integrated campus” in the city, into just one location, as per the WARN letter. “We presently expect this action to be permanent,” wrote Camilo Cobos, the biotech’s vice president of human resources.

Disease Area: Endocrinology, Hematology, Multiple, Rare Diseases, Respiratory Diseases
Drug Type: Biologic, Small Molecule
Scroll to Top